ELAVL2 and small cell lung carcinoma: The three other family members, ELAVL2, ELAVL3 and ELAVL4, initially received much attention as neuroendocrine markers for small cell lung cancer (SCLC) (King, 1997; D'Alessandro et al., 2008).